Insurers Must Pay Pharma Co. Defense Costs In SEC Probe

By Ruben Castaneda · February 13, 2024, 8:38 PM EST

A drug development company formed by a merger is entitled to insurance payments for expenses it paid two of its former officers in connection with federal subpoenas because the insurer failed...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Amtrust International Underwriters DAC v. 180 Life Sciences Corp.

Case Number

Court

California Northern

Nature of Suit

Insurance

Date Filed

June 29, 2022

Recent Articles By Ruben

February 08, 2024
FDA Settles Allegations Of Uneven Blood Treatment Standards
February 06, 2024
Sheppard Mullin Adds Partner From Faegre Drinker In Chicago
February 05, 2024
Tennessee Asks Justices To Keep Gender-Affirming Care Ban
January 31, 2024
FDA May Have To Cut Activities As Need to Regulate AI Grows
January 19, 2024
Ohio Court Blesses Atty's 'Zealous' Strategy, Axes Sanctions
January 05, 2024
NJ Brothers Ordered To Prison For Prescription Drug Scheme
January 04, 2024
Hospital Network Told To Provide Contracts In Antitrust Suit
December 20, 2023
Medical Device Cos. Settle Trade Secrets Suit For $8M
December 19, 2023
Anesthesiologists Say CMS Reimbursement Math Is Unlawful
December 15, 2023
Ky. Hospital Didn't Do Enough To Stop Data Breach, Suit Says